Osaic Holdings
ELDN icon

Osaic Holdings’s Eledon Pharmaceuticals ELDN Stock Holding History

Osaic Holdings’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.7K Buy
7,030
+6,625
+1,636% +$24.1K ﹤0.01% 5911
2026
Q1 		$1.25K Hold
405
– – ﹤0.01% 7195
2025
Q4 		$611 Sell
405
-9,595
-96% -$22.8K ﹤0.01% 7401
2025
Q3 		$25.9K Buy
+10,000
New +$29.2K ﹤0.01% 5761

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Osaic Holdings's ELDN Position: Q2 2026 in Review

Osaic Holdings increased its Eledon Pharmaceuticals (ELDN) stake by 1,636% in Q2 2026, buying an estimated $24.1K and bringing the position to 7,030 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5911.

Osaic Holdings first reported a position in ELDN in Q3 2025 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Osaic Holdings held 7,030 shares of Eledon Pharmaceuticals worth $27.7K as of Q2 2026.
  • Osaic Holdings bought 6,625 Eledon Pharmaceuticals shares in Q2 2026, an estimated $24.1K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5911 holding.
  • Osaic Holdings first reported a position in Eledon Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.